Last reviewed · How we verify

NCT06795308

The Effect of Position on Pain, Bleeding, Hematoma and Vital Signs After Transfemoral Coronary Angiography

Not yet recruiting NA Last updated 5 February 2025
What this trial tests

NA trial testing Bed Position and Head Elevation in Coronary Disease in 60 participants. Not yet recruiting.

Timeline
3 February 2025
Primary endpoint
30 May 2025
30 May 2025

Quick facts

Lead sponsorMersin University
PhaseNA
StatusNot yet recruiting
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposesupportive care
Enrollment60
Start date3 February 2025
Primary completion30 May 2025
Estimated completion30 May 2025
Sites1 location across Turkey (Türkiye)

Drugs / interventions tested

Conditions studied

Sponsor

Mersin University

Who can join

18 Hours and older, any sex, with Coronary Disease or Angiography. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

In this study, it was aimed to determine the effect of the special position given to the patient after transfemoral coronary angiography (supine position that varies depending on the angles) on pain, bleeding, hematoma and vital signs.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

Other Mersin University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06795308.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing